Analysts at Guggenheim Securities upgraded Comerica CMA from “neutral” to “buy.”
The target price for Comerica has been raised from $54 to $58.
Comerica shares have jumped 20.83% the past 52 weeks, while the S&P 500 index has gained 18.82% in the same period.
Comerica's shares fell 0.52% to $50.04 in pre-market trading.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in